Utama › Kanser Paru-paru › Colorado › Aurora
Kajian klinikal Kanser Paru-paru di Aurora, CO
19 kajian untuk Kanser Paru-paru sedang mencari peserta di lokasi dalam dan sekitar Aurora (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Mengambil pesertaFasa 3
- Rocky Mountain Cancer Centers-Aurora, Aurora
- UCHealth University of Colorado Hospital, Aurora
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Mengambil pesertaFasa 3
- Rocky Mountain Cancer Centers-Aurora, Aurora
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
- University of Colorado Cancer Center, Aurora
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Mengambil pesertaFasa 1/2
- University of Colorado - Aurora Cancer Center, Aurora
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
- University of Colorado Health Hospital, Aurora
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Mengambil pesertaFasa 1
- University of Colorado Cancer Center, Aurora
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Mengambil pesertaFasa 3
- University of Colorado Health, Aurora
Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung
Mengambil pesertaFasa 3
- University of Colorado Hospital, Aurora
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- UCHealth University of Colorado Hospital, Aurora
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- UCHealth University of Colorado Hospital, Aurora
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- UCHealth University of Colorado Hospital, Aurora
Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements
Mengambil pesertaFasa 1/2
- University of Colorado Cancer Center, Aurora
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
Mengambil pesertaKajian pemerhatian
- University of Colorado Cancer Center, Aurora
Improving Care for Rural Patients With Solid Tumors
Mengambil peserta
- University of Colorado Hospital, Aurora
Specimen Banking From Patients With Lung Cancer
Mengambil pesertaKajian pemerhatian
- University of Colorado Cancer Center, Aurora
Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer
Mengambil peserta
- Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Aurora
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Mengambil pesertaKajian pemerhatian
- University of Colorado Cancer Center at UC Health Sciences Center, Aurora
Kajian Kanser Paru-paru di bandar lain
- Houston, TX78 kajian
- Boston, MA62 kajian
- New York City, NY60 kajian
- Los Angeles, CA45 kajian
- Washington, DC41 kajian
- Arlington, VA41 kajian
- Chicago, IL41 kajian
- Nashville, TN40 kajian
- Baltimore, MD40 kajian
- St. Louis, MO39 kajian
- Columbus, OH37 kajian
- Philadelphia, PA36 kajian
Kajian lain di Aurora
- Kanser (semua jenis)35 kajian
- Kanser Kolorektal32 kajian
- Kanser Paru-paru Bukan Sel Kecil30 kajian
- Kanser Payudara27 kajian
- Kanser Metastatik25 kajian
- Kanser Ovari25 kajian
- Diabetes Jenis 123 kajian
- Obesiti21 kajian
- Kanser Prostat19 kajian
- Kegagalan Jantung18 kajian
- Melanoma18 kajian
- Leukemia Mieloid Akut16 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.